News
FILAMENT HEALTH ANNOUNCES FIRST-EVER COMPASSIONATE USE APPROVAL FOR PSILOCYBIN IN THE EUROPEAN UNION
Filament's botanical psilocybin drug candidate PEX010 to be administered in Germany for treatment-resistant depression ...
"We are delighted to be partnering with an organization known for its quality and expertise in oligonucleotide chemistry sequencing," said Mr. Bitterman, Phio's President and CEO. "Additionally, we ...
WHAT if I told you that some of the most in-demand tech skills of the year 2030 aren’t futuristic at all? In fact, you can start learning them today. That’s kind of wild when you think about it—but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results